TEVA PHARMACEUTICAL INDUSTRIES LIMITED Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount of $262.00 million as of 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions · last filed 2026-02-03
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount $262.00M.
- 2024-12-31: Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount $217.00M.
- 2023-12-31: Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount $192.00M.
- 2022-12-31: Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount $181.00M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount |
|---|---|
| 2025-12-31 | $262.00M 10-K · filed 2026-02-03 |
| 2024-12-31 | $217.00M 10-K · filed 2025-02-05 |
| 2023-12-31 | $192.00M 10-K · filed 2024-02-12 |
| 2022-12-31 | $181.00M 10-K · filed 2023-02-10 |